海利生物：控股子公司三类医疗器械注册申请获得受理

Core Viewpoint - Haili Biological announced that its subsidiary, Ruisheng Biological, has had its Class III medical device "Natural Bone Repair Material" registration application accepted by the National Medical Products Administration, which is expected to enhance its product line in the oral bone defect repair sector [1] Group 1 - The product is designed for maxillary bone defect repair and utilizes a more efficient production process, leading to faster and more stable bone repair outcomes [1] - Approval of the product for market launch will diversify Ruisheng Biological's offerings in the oral bone defect repair field [1]